Despite declines in Bitcoin and Ethereum prices, ETF products tracking Hyperliquid’s ecosystem token HYPE have attracted significant inflows. The spot HYPE ETFs launched by Bitwise and 21Shares in May this year (ticker symbols BHYP and THYP) have collectively attracted $150 million in assets, while Grayscale’s newly launched Hyperliquid Staking ETF (HYPG) this week has reached $4.5 million in assets under management. To date, the 21Shares Hyperliquid ETF has $75.8 million in assets under management, and the Bitwise Hyperliquid ETF has $71.1 million. The Hyperliquid platform has drawn investor interest through its mechanism of using fee revenue to repurchase HYPE tokens, but its use in the U.S. remains restricted, with regulatory approval potentially not arriving until 2027.
Hyperliquid HYPE ETFs Attract $150M in Inflows Amid Crypto Price Declines
AiCoinShare
Summary
Hyperliquid HYPE ETFs attracted $150 million in inflows as crypto price news showed Bitcoin and Ethereum declining. Bitwise and 21Shares’ HYPE spot ETFs (BHYP and THYP), launched in May 2026, now hold $71.1 million and $75.8 million, respectively. Grayscale’s HYPG added $4.5 million this week. The token buyback model has drawn attention, but U.S. access remains limited. Bitcoin ETF news underscores growing interest in alternative crypto exposure. Regulatory approval for U.S. use may not arrive until 2027.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.